Inventor · disambiguated record
Jonas Helma-Smets
Also filed as: HELMA-SMETS JONAS
5 granted patents·10 pending applications·1 citations·filing 2017–2025
64Inventor score
Top patents by PatentIndex Score
15 records- 0179US2025090672A1Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidatesFORSCHUNGSVERBUND BERLIN EV·Filed 2024·Application pending·0 cites
- 0278US12171837B2Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidatesFORSCHUNGSVERBUND BERLIN EV·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 0374US11161873B2Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidatesFORSCHUNGSVERBUND BERLIN EV·Filed 2017·Granted Nov 2, 2021·1 cites·38 claims
- 0470US11746124B2Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidatesFORSCHUNGSVERBUND BERLIN EV·Filed 2021·Granted Sep 5, 2023·0 cites·26 claims
- 0568US2025281634A1Conjugates comprising a phosphorus (v) and a drug moietyTUBULIS GMBH·Filed 2025·Application pending·0 cites
- 0665US2023330258A1Conjugates comprising a phosphorus (v) and a drug moietyTUBULIS GMBH·Filed 2022·Application pending·0 cites
- 0755US2024269313A1Conjugates comprising a phosphorus(v) moiety and a drugTUBULIS GMBH·Filed 2023·Application pending·0 cites
- 0855US2023158154A1Conjugates comprising a phosphorus (v) and a camptothecin moietyTUBULIS GMBH·Filed 2022·Application pending·0 cites
- 0954US2024245798A1Novel anti-tpbg antibody and antibody-drug-conjugates based thereon, therapeutic methods and uses thereofTUBULIS GMBH·Filed 2023·Application pending·0 cites
- 1054US2024182596A1Anti-napi2b antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereofTUBULIS GMBH·Filed 2023·Application pending·0 cites
- 1154US2024190958A1Novel antibody drug conjugates with novel napi2b antibodies, therapeutic methods and uses thereofTUBULIS GMBH·Filed 2023·Application pending·0 cites
- 1254US2025049939A1Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitorsTUBULIS GMBH·Filed 2022·Application pending·0 cites
- 1351US2022193251A1Cd30 targeting antibody drug conjugates and uses thereofUNIV MUENCHEN LUDWIG MAXIMILIANS·Filed 2021·Application pending·0 cites
- 1446US12453779B2Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonatesFORSCHUNGSVERBUND BERLIN EV·Filed 2019·Granted Oct 28, 2025·0 cites·11 claims
- 1540US11572384B2Unusual substrates of tubulin tyrosine ligaseFORSCHUNGSVERBUND BERLIN EV·Filed 2017·Granted Feb 7, 2023·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Jonas Helma-Smets files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →